secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001477449-24-000083
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc CEO Jason Gorevic departs; CFO Mala Murthy named acting CEO
-------------------------------------------------------------------

- Jason Gorevic departs immediately; Board retains search firm for permanent successor.
- CFO Mala Murthy appointed acting CEO, retains CFO role; base salary raised to $750k, target bonus 120%, additional equity $1.1M.
- Company reaffirms Q1 2024 and full-year 2024 guidance, consistent with Feb 20 earnings release.
- Gorevic eligible for separation benefits per employment agreement subject to release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744924000083/0001477449-24-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744924000083/tdoc-20240405.htm
  HTML page:      https://secwatch.observer/filing/0001477449-24-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer